Ugur Sahin, founder and chief executive officer of Germany-based BioNTech, sees the potent efficacy of BNT162b2 – the vaccine developed by his company and partner Pfizer – as the possible “beginning of the end” of the coronavirus pandemic.
Russia’s Sputnik V vaccine is 92% effective at protecting people from Covid-19 according to interim trial results, the country’s sovereign wealth fund said, as Moscow rushes to keep pace with Western drugmakers in the race for a shot.
There were more than 59,000 Covid-19 patients in hospitals across the United States on Nov. 9, the country’s highest number ever of in-patients being treated for the disease, with new infections at record levels for the sixth consecutive day.
The coronavirus pandemic raged across the United States as the country elected a new president, with the daily number of new infections hitting record highs for four straight days.
Pfizer Inc.’s experimental Covid-19 vaccine was more than 90% effective based on initial trial results, the company said, a major victory in the fight against a pandemic that has killed more than 1 million people and battered the world’s economy.
In this webinar, U.S. experts discuss how educational facilities can adapt to a changing e-learning environment while maintaining compliance in the legal and employment sectors.
Global coronavirus infections exceeded 50 million, according to a Reuters tally, with a second wave of the virus in the past 30 days accounting for a quarter of the total.
The United States became the first nation since the pandemic began to surpass 10 million coronavirus infections, according to a Reuters tally, as the third wave of the Covid-19 virus surges across the country.
Illinois-based Abbott is suing their former VP Jerome Clavel over allegations of trade secret theft with intent to share with his new employer, rival diagnostics company Bio-Rad.
While the world has largely been focused on the development of vaccines and therapeutics for Covid-19, the U.S. Food and Drug Administration has remained busy lining up potential approvals of medications for other diseases and illnesses.